Home » Authors » Jim Stommen

Articles by Jim Stommen

Frost & Sullivan Medical Technologies 2006: Dealmaking at both macro and micro levels is in the air

March 15, 2006

Frost & Sullivan Medical Technologies 2006: Opportunities seen in chronic diseases, infection control

March 14, 2006

Boston gathering to focus on investing in area's med-tech

March 9, 2006

Boston conference's focus is investing in area's med-tech

March 7, 2006

Cardio companies draw substantial investor interest

March 1, 2006

Growing markets hike interest in diagnostics, orthopedics companies

Feb. 1, 2006

Cardio firms attract interested listeners at investor gathering

Feb. 1, 2006

JPMorgan Healthcare Conference: Roche's Hunziker eyes some of bigger-picture challenges

Jan. 20, 2006

Lab equipment makers pushing new systems to meet lab needs

Jan. 19, 2006

Diag firms attract investor interest as test value grows

Jan. 19, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 18, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 18, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...